-
Itopride, a D2 dopamine agonist with anticholinesterase effects, was marginally superior to placebo in 'functional dyspepsia.'
-
Visual hallucinations, extrapyramidal motor signs, and visuoconstructional impairments at time of presentation are strongly suggestive of a diagnosis of dementia with Lewy bodies.
-
A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker).
-
-
There is a wide variation in the rate of coronary heart disease (CHD) in diabetes, depending on the population and existing risk factors.
-
The availability of a growing number of therapeutic options for acute stroke patients makes rapid and reliable diagnosis of stroke at the bedside more important than ever.
-
Noninferiority trials are usually designed to show that product B, which entered the therapeutic arena after product A, does not fall below a prespecified margin of efficacy compared to product A, ...
-
It has been a tough few months for marketers of vitamins and herbal products. Calcium plus vitamin D, saw palmetto, and glucosamine/chondroitin have all been the subject of studies that have questioned their efficacy.
-
Long-term use of warfarin is associated with an increase in osteoporotic fractures.
-
The fda has approved a new drug with a unique mechanism of action for the treatment of chronic angina. Ranolazine reduces the frequency of chest pains by reducing the demand for oxygen but does not have significant effect on heart rate or blood pressure.
